Assessment of LDL-C and triglycerides efficacy of atorvastatin at different starting doses in patients with Type 2 diabetes

被引：0

作者：

Hey-Hadavi, J ^{[1
]}

Laskey, R ^{[1
]}

Yurkovic, C ^{[1
]}

Palmer, G ^{[1
]}

机构：

[1] Pfizer Inc, New York, NY USA

来源：

DIABETOLOGIA | 2003年 / 46卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1026

引用

页码：A353 / A354

页数：2

共 50 条

[31] ECONOMIC OUTCOMES ASSOCIATED WITH HBA1C AND LDL-C GOAL ACHIEVEMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Shi, L.
Ye, X.
Lu, M.
Wu, E. Q.
Sharma, H.
Thomason, D.
Fonseca, V
VALUE IN HEALTH, 2013, 16 (03) : A172 - A172
[32] Enhanced attainment of optional recommended levels of LDL-C, apolipoprotein B, non-HDL and hsCRP in type 2 diabetes patients treated with ezetimibe/simvastatin compared to atorvastatin
Weinstock, Ruth S.
Goldberg, Ronald B.
Guyton, John R.
Mazzone, Theodore
Polis, Adam
Tomassini, Joanne E.
Desrosiers, Elizabeth
Tershakovec, Andrew M.
CIRCULATION, 2006, 114 (18) : 796 - 797
[33] Characteristics of type 2 daibete with LDL-C controlled or not reaching the goals for LDL-C and non-apolipoprotein B
Querton, L.
Buysschaert, M.
Hermans, M. P.
DIABETES & METABOLISM, 2011, 37 : A78 - A78
[34] Comparison of a direct assay against the Friedewald Formula results for LDL-C in patients with Type 2 Diabetes Mellitus.
Ross, D.
Twomey, P. J.
IRISH JOURNAL OF MEDICAL SCIENCE, 2019, 188 : S246 - S246
[35] Therapeutic options for lowering LDL-C in type 2 diabetes: A nurse practitioner's perspective
Lew, Kelley Newlin
Kent, Daniel J.
Munoz, Angelica A.
Melkus, Gail D'Eramo
JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2013, 25 (09) : 488 - 494
[36] Impact of glycemic control on LDL-C cholesterol goal attainment in type 2 diabetes mellitus
Isley, WL
Reznick, L
Weiss, TW
Nag, SS
Gardyn, JL
Lu, JD
Kovacich, D
Alexander, CM
DIABETES, 2001, 50 : A144 - A144
[37] Safety and efficacy of atorvastatin at very low LDL-C levels - A post hoc analysis of the TNT study
LaRosa, JC
Grundy, SM
Kastelein, JJ
Kostis, JB
CIRCULATION, 2005, 112 (17) : U726 - U727
[38] LOWER LDL-C TARGET-GOAL ACHIEVEMENTS IN PATIENTS WITH ACUTE CEREBRAL INFARCTION COMBINED WITH TYPE 2 DIABETES
Chen, Z.
Zhang, Y.
ATHEROSCLEROSIS, 2023, 379 : S83 - S83
[39] Marked reduction in LDL cholesterol (LDL-c) with ezetimibe (E) and concurrent Stalin (S) treatment in type 2 diabetes
Wolfe, GS
King, AB
DIABETES, 2004, 53 : A152 - A152
[40] Efficacy of atorvastatin for achieving cholesterol targets after LDL-cholesterol based dose selection in patients with type 2 diabetes
Carlos Ferrer-Garcia, Juan
Sanchez-Ballester, Eva
Albalat-Galera, Raquel
Berzosa-Sanchez, Miguel
Herrera-Ballester, Agustin
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2008, 13 (03) : 183 - 188

← 1 2 3 4 5 →